Wilms tumour 1 peptide vaccine as a cure-oriented post-chemotherapy strategy for patients with acute myeloid leukaemia at high risk of relapse.
Jun NakataYoshiki NakaeManabu KawakamiSoyoko MorimotoDaisuke MotookaNaoki HosenFumihiro FujikiHiroko NakajimaKana HasegawaSumiyuki NishidaAkihiro TsuboiYusuke OjiYoshihiro OkaAtsushi KumanogohHaruo SugiyamaPublished in: British journal of haematology (2017)